Chronic Training in the blind field for Stroke
This study is evaluating whether there are changes in plastic potential of the visual system with time from stroke affecting primary visual cortex.
See full descriptionAbout the trial for Stroke
Treatment Groups
This trial involves 2 different treatments. Chronic Training In The Blind Field is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 18 and older. There are 8 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Chronic Training in the blind field will improve 1 primary outcome, 6 secondary outcomes, and 3 other outcomes in patients with Stroke. Measurement will happen over the course of baseline, 6 months, 12 months.
Who is running the study
Principal InvestigatorPatient Q & A Section
How many people get stroke a year in the United States?
Approximately 534,000 Americans die from stroke a year. This is comparable to the number of [lung cancer](https://www.withpower.com/clinical-trials/lung-cancer) deaths, but almost twice as large as those from all other cancers combined.
What are common treatments for stroke?
Of all stroke patients in a community, 8% were being treated with aspirin, 33% with statins, and 15% with drugs to prevent VTE. Antihypertensive agents were administered to less than 20% of the population. Thrombolytic therapy is widely used in the early treatment of stroke.
Can stroke be cured?
The question of whether one can cure oneself of an ipsilateral ischemic stroke remains unresolved. Future studies should focus on whether it is possible to prevent other strokes.
What are the signs of stroke?
The signs of the stroke may be similar to those of a heart attack, although a heart attack can occur without the signs appearing in most cases.\n
What causes stroke?
The cause of stroke is not completely understood, but there are identifiable risk factors for stroke to be a woman, age 60 and older, diabetes, heart disease, and atherosclerosis.
What is stroke?
Stroke is a condition in which the brain acquires a shortage of blood supply (ischemia) which can lead to a temporary or permanent loss of function. Most common in people over 65 years of age, strokes occur when an artery supplying blood (typically, the blood vessels that emerge from the brain's brain) becomes blocked, and there is an insufficient amount of blood flowing through this artery, leading to a lack of oxygenated blood in the brain tissue. The loss of oxygen can damage the cells that make up the nerve membrane in the brain, leading to a neurological condition called a stroke.
Who should consider clinical trials for stroke?
Although there seems to be a consensus that a majority of patients with a first clinical episode of stroke should undergo a trial of medication, a discrepancy exists in patient selection between trial providers and providers of stroke care. Inclusion and exclusion criteria are used inconsistently, resulting in suboptimal patient-provider communication and communication between the healthcare system and trial providers. There remains a lack of evidence-based guidelines and an undefined gap between guideline recommendations and current practice. Further education and clinical trials focused on addressing selection criteria for clinical trials of stroke treatment could improve patient outcomes during time of the acute stroke.
What is the average age someone gets stroke?
When a stroke happens, there is a peak in number of strokes during the third and fourth decades. Therefore, education about stroke in the population should be initiated at least during the early thirties, in order to protect the population against stroke when they grow up.
Have there been other clinical trials involving chronic training in the blind field?
Findings from a recent study of our study showed that training in the blind field with a specialised visuomotor rehabilitation system has the potential to produce gains in performance. Findings from a recent study of this study have relevance for a range of neurodegenerative disorders and underscore previous findings that cognitive training in the brain-lesioned hemisphere is beneficial.
What does chronic training in the blind field usually treat?
It was determined that the specific training for the blind that is used in the study is effective in the treatment of this unilateral chronic visual loss.
What is chronic training in the blind field?
In a recent study, findings indicate that there is no significant change in the sensory function or visual field in the blind field after intensive training. The improvement found in the amplitude of P100 and N170 in the test subjects suggests that this training has had an improvement in temporal resolution. The significant decrease in P100 amplitude in the second session compared to baseline implies that this is possibly related to the learning of the visual stimulus. The significant improvement observed in the N170 amplitude at baseline and during the second session indicates the development of a visual perception before the training. In a recent study, findings emphasize the role of training in the blind field in which visual development and training in the blindness are important in the rehabilitation.
What is the primary cause of stroke?
Two strokes have relatively benign ischemic presentations with a low stroke burden compared with four strokes. The relative benignity of strokes occurring in 4 strokes may be explained by the frequent occurrence of small vessel disease in 4 strokes.